Results 241 to 250 of about 128,840 (306)

Longitudinal changes in NT-proBNP after breast cancer radiotherapy: clinical determinants of its trajectory and association with cardiac dysfunction (BACCARAT study). [PDF]

Clin Transl Radiat Oncol
Locquet M, Jimenez G, Camilleri J, Broggio D, Lairez O, Panh L, Tarlet G, Ferrières J, Milliat F, Jacob S.   +9 more
europepmc   +1 more source

A New Option for the Management of Dyslipidemias: Advances in Research on the Small Interfering RNA Drug Inclisiran. [PDF]

Rev Cardiovasc Med
Wu X, Zhang J.
europepmc   +1 more source

Severe Hyperlipidemia and Multifocal Atherosclerosis With Negative Genetic Testing for Familial Hypercholesterolemia: A Case Report. [PDF]

Cureus
Buczyński D, Róg A, Pałka M, Susuł M, Rajtar-Salwa R.   +4 more
europepmc   +1 more source

(Can. J. Biochem., 60:556-563)Plasma methyl sterol sulfates in familial hypercholesterolemia after ileal bypass

, 2014
Masse, R., Eid, K., Laliberte, C., Davignon, J., Y. S. Huang   +4 more
core  

Some of the next articles are maybe not open access.

Related searches:

The Inherited Hypercholesterolemias

Endocrinology and Metabolism Clinics of North America, 2022
Inherited hypercholesterolemias include monogenic and polygenic disorders, which can be very rare (eg, cerebrotendinous xanthomatosis (CTX)) or relatively common (eg, familial combined hyperlipidemia [FCH]). In this review, we discuss familial hypercholesterolemia (FH), FH-mimics (eg, polygenic hypercholesterolemia [PH], FCH, sitosterolemia), and other
Wann Jia, Loh, Gerald F, Watts
openaire   +2 more sources